Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study

Abstract Background The topic of trastuzumab therapy without chemotherapy in early breast cancer (EBC) has been repeatedly discussed at international consensus meetings, but is compromised by the lack of solid evidence from clinical studies. Methods An observational study database of patients with E...

Full description

Bibliographic Details
Main Authors: Peter Dall, Thorsten Koch, Thomas Göhler, Johannes Selbach, Andreas Ammon, Jochen Eggert, Nidal Gazawi, Daniela Rezek, Arthur Wischnik, Carsten Hielscher, Nicolas Schleif, Ursula Cirrincione, Axel Hinke, Gabriele Feisel-Schwickardi
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Cancer
Subjects:
HER2-positive
Monotherapy
Overall survival
Propensity score analysis
Relapse-free survival
Online Access:http://link.springer.com/article/10.1186/s12885-017-3857-5

Internet

http://link.springer.com/article/10.1186/s12885-017-3857-5

Similar Items